drugset / Trial / NCT02985671

To Evaluate the Superiority of Fixed Combination (Orfenadrine 35mg, Acetaminophen 325mg, Caffeine 65mg and Diclofenac Sodium 50mg) Compared to Voltaren® (Diclofenac Sodium 50mg) in the Treatment of Acute Postural Low Back Pain.

NCT02985671

Phase 3 Unknown 110 enrolled Ache Laboratorios Farmaceuticos S.A.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether the fixed combination of orphenadrine, acetaminophen, caffeine and diclofenac sodium is more effective in the treatment of an acute episode of mechanical postural low back pain than Voltaren®. Will be randomized 110 participants of both sexes, aged 18 years or older and less than 65 years of age with an acute episode of mechanical postural low back pain and they will be allocated to one of two treatment groups: Group 1: Fixed combination of orphenadrine, acetaminophen, caffeine and diclofenac sodium; or Group 2: Voltaren®

Timeline

Start
2021-01
Primary completion
2021-09
Completion
2021-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 325 mg Oral
Subject Caffeine Small molecule 65 mg Oral
Comparator Diclofenac Other / unclassified 50 mg Oral
Subject Orphenadrine Small molecule 35 mg Oral

Indications

No indication recorded.